Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to KIDNEY CANCER/RCC

The New England Journal of Medicine

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

Oncology, Medical April 29th 2024

Cancer Therapy Advisor

Exploring First-Line Treatments: ASCO GU 2024 Update on Advanced Renal Cell Carcinoma

Oncology, Medical April 1st 2024

The New England Journal of Medicine

Adjuvant Pembrolizumab after Nephrectomy in Renal Cell Carcinoma

Nephrology February 20th 2024

Dana-Farber Cancer Institute

Immunotherapy Post-Surgery Improves Overall Survival For Kidney Cancer

Oncology, Medical February 12th 2024

Oncology News Central (ONC)

A Tale of Two ICIs: Adjuvant Pembro Ups Survival in RCC, Nivo Doesn’t

Oncology, Medical February 5th 2024

Dana-Farber Cancer Institute

FDA Approves Kidney Cancer Therapy After Dana-Farber-Led Research Shows Improved Outcomes For Patients with Advanced Disease

Nephrology January 8th 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form